These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24281232)

  • 21. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples.
    Siddiqui MT; Saboorian MH; Gokaslan ST; Ashfaq R
    Cancer; 2002 Feb; 96(1):49-52. PubMed ID: 11836703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of arginase-1 expression in distinguishing hepatocellular carcinoma from non-hepatocellular tumors].
    Sang W; Gulinar A; Wang CH; Sheng WQ; Maiweilidan Y; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):538-42. PubMed ID: 24246920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginase-1 is a novel immunohistochemical marker of hepatocellular differentiation.
    Ordóñez NG
    Adv Anat Pathol; 2014 Jul; 21(4):285-90. PubMed ID: 24911253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Well differentiated arginase-1 negative hepatocellular carcinoma.
    Obiorah IE; Chahine J; Park BU; Ko K; deGuzman J; Kallakury B
    Transl Gastroenterol Hepatol; 2019; 4():66. PubMed ID: 31620648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
    Nassar A; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alanine-glyoxylate aminotransferase 1 (AGXT1) is a novel marker for hepatocellular carcinomas.
    Zhao CL; Hui Y; Wang LJ; Yang D; Yakirevich E; Mangray S; Huang CK; Lu S
    Hum Pathol; 2018 Oct; 80():76-81. PubMed ID: 29883780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of pancreatic digestive enzyme immunohistochemistry in the differential diagnosis of hepatocellular carcinoma, cholangiocarcinoma and metastatic adenocarcinoma of the liver.
    Terada T; Nakanuma Y
    Pathol Int; 1996 Mar; 46(3):183-8. PubMed ID: 10846568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma.
    Lagana SM; Salomao M; Remotti HE; Knisely AS; Moreira RK
    Histopathology; 2015 Mar; 66(4):598-602. PubMed ID: 25378077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological features and differential diagnosis of hepatocellular carcinoma in extrahepatic metastases.
    Chen D; Li Z; Song Q; Qian L; Xie B; Zhu J
    Medicine (Baltimore); 2018 Dec; 97(50):e13356. PubMed ID: 30557986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
    Geramizadeh B; Boub R; Rahsaz M
    Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.
    Shahid M; Mubeen A; Tse J; Kakar S; Bateman AC; Borger D; Rivera MN; Ting DT; Deshpande V
    Am J Surg Pathol; 2015 Jan; 39(1):25-34. PubMed ID: 25353287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of glypican-3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
    Wang C; Shao X; Zhang X; Xie C; Yu J; Xu X; Yang J; Li Y; Xu W
    Transl Cancer Res; 2020 Jan; 9(1):128-136. PubMed ID: 35117166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas.
    Fujikura K; Yamasaki T; Otani K; Kanzawa M; Fukumoto T; Ku Y; Hirose T; Itoh T; Zen Y
    Am J Surg Pathol; 2016 May; 40(5):689-96. PubMed ID: 26735860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type.
    Akiba J; Nakashima O; Hattori S; Naito Y; Kusano H; Kondo R; Nakayama M; Tanikawa K; Todoroki K; Umeno Y; Nakamura K; Sanada S; Yamaguchi R; Ogasawara S; Yano H
    J Clin Pathol; 2016 Oct; 69(10):846-51. PubMed ID: 26969740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatoid Teratoma, Hepatoid Yolk Sac Tumor, and Hepatocellular Carcinoma: A Morphologic and Immunohistochemical Study of 30 Cases.
    Al-Obaidy KI; Williamson SR; Shelman N; Idrees MT; Ulbright TM
    Am J Surg Pathol; 2021 Jan; 45(1):127-136. PubMed ID: 32991342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
    Lin F; Abdallah H; Meschter S
    Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
    Simms A; Jacob RP; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte paraffin-1, CD10, and CD34 immunostaining as a diagnostic aid in cytologic diagnosis of hepatic cancer.
    Agarwal A; Handa U; Kundu R; Sachdev A; Kochhar S
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S434-S438. PubMed ID: 36510999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galectin-3 and PTEN expression in pancreatic ductal adenocarcinoma, pancreatic neuroendocrine neoplasms and gastrointestinal tumors on fine-needle aspiration cytology.
    Jiang K; Lawson D; Cohen C; Siddiqui MT
    Acta Cytol; 2014; 58(3):281-7. PubMed ID: 24854395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma.
    Varma V; Cohen C
    Adv Anat Pathol; 2004 Sep; 11(5):239-49. PubMed ID: 15322490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.